"We are surprised by the significant drop in our share price following the election results in Bulgaria," said Rick Howes, President and CEO. "We do not foresee any fundamental changes that would affect our Chelopech mine, which is fully permitted at all government levels. We have a strong balance sheet, generate solid margins, and have more than $250 million of cash and undrawn lines of credit to fully fund all of our capital commitments."
Dr. Moll, age 60, co-founder of Hansen, has served as a member of our Board of Directors since our inception in September 2002, and previously served as our Chief Executive Officer since our inception in September 2002 until June 2010, as our President from March 2009 until June 2010, and as our Executive Chairman of the Board from June 2010 until December 2011. In November 1995, Dr. Moll co-founded Intuitive Surgical Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director until September 2003.
3 Biotechs With Upcoming Product Launches [View article]
SpectreKaos,
I already sold my ALXA shares after the news spike.
"The Company recognizes milestone payments utilizing the milestone method of revenue recognition. The Company is eligible to receive up to $8.0 million of milestone payments from Grupo Ferrer. The Company will recognize milestone revenue upon first commercial sales in each of nine (9) identified countries. The Company believes each of these milestones are substantive as there is uncertainty that the milestones will be met, the milestone can only be achieved with the Company’s past and current performance and the achievement of the milestone will result in additional payment to the Company. To date, the Company has not recognized any milestone revenue. The Company will record royalty revenues in the period certain cumulative sales targets are met by Grupo Ferrer."
http://bit.ly/14ESvjd Also: In March 2012, the Company entered into an amendment to the Ferrer Agreement. Ferrer and the Company agreed to eliminate a future potential milestone payment in exchange for Ferrer’s purchase of $3 million of the Company’s common stock. Ferrer purchased 241,936 shares of the Company’s common stock for $12.40 per share in March 2012, which reflected a premium on the fair value of the Company’s common stock of approximately $1,452,000.
2 Biotechs And A Retailer With Recent Intensive Insider Selling [View article]
We just got an insider buy transaction in ACAD:
http://bit.ly/126ZYe0
2 Healthcare Companies With Recent Intensive Insider Buying [View article]
That is why I wrote:
"The company has a book value of $20.67 per share, which could be a good entry point for the stock."
1 Bank, 1 Electric Utility And 1 Gold Stock With Recent Intensive Insider Buying [View article]
Nice up tick on Friday:
http://bit.ly/10TvXXD
1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling [View article]
Sorry to hear this.
2 Basic Materials Stocks With Recent Intensive Insider Buying [View article]
I agree.
"We are surprised by the significant drop in our share price following the election results in Bulgaria," said Rick Howes, President and CEO. "We do not foresee any fundamental changes that would affect our Chelopech mine, which is fully permitted at all government levels. We have a strong balance sheet, generate solid margins, and have more than $250 million of cash and undrawn lines of credit to fully fund all of our capital commitments."
http://yhoo.it/10rV0Cp
1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling [View article]
The Point and Figure chart is currently pointing to $94 in VRTX:
http://bit.ly/10rU7cY
1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling [View article]
Correct, there has been insider selling in IBM during the past 2 years and the price is still about the same:
http://bit.ly/14Xvqbt
1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling [View article]
The gift to charitable organization was not included in the sales that I reported:
http://1.usa.gov/Z4pYTy
1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling [View article]
You are right. Here is the link:
http://bit.ly/14XtXlr
The insiders still made a nice profit.
2 Tech Stocks And 1 Healthcare Company With Recent Intensive Insider Selling [View article]
The chart for LNKD turned bearish again:
http://bit.ly/UZB78H
2 Basic Materials Stocks With Recent Intensive Insider Buying [View article]
I did buy some DPMLF. The price drop is mainly due to sector weakness and the latest earnings report.
1 Biotech, 1 Financial And 1 Consumer Goods Company With Recent Intensive Insider Selling [View article]
Netflix is already in the list:
http://seekingalpha.co...
2 Gold Stocks And A Potash Company With Recent Intensive Insider Buying [View article]
I agree with your analysis. I am still long BRD. The insiders are still buying BRD:
http://bit.ly/18hihw3
and many other miners. The ratio is currently 10 to 1:
http://bit.ly/193tr8I
I would expect the sector to bottom this summer.
2 Healthcare Companies With Recent Intensive Insider Buying [View article]
Here is the full story of Dr Frederic Moll:
http://bit.ly/115Aqw9
Dr. Moll, age 60, co-founder of Hansen, has served as a member of our Board of Directors since our inception in September 2002, and previously served as our Chief Executive Officer since our inception in September 2002 until June 2010, as our President from March 2009 until June 2010, and as our Executive Chairman of the Board from June 2010 until December 2011. In November 1995, Dr. Moll co-founded Intuitive Surgical Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director until September 2003.
http://onforb.es/117bzlR
3 Biotechs With Upcoming Product Launches [View article]
I already sold my ALXA shares after the news spike.
"The Company recognizes milestone payments utilizing the milestone method of revenue recognition. The Company is eligible to receive up to $8.0 million of milestone payments from Grupo Ferrer. The Company will recognize milestone revenue upon first commercial sales in each of nine (9) identified countries. The Company believes each of these milestones are substantive as there is uncertainty that the milestones will be met, the milestone can only be achieved with the Company’s past and current performance and the achievement of the milestone will result in additional payment to the Company. To date, the Company has not recognized any milestone revenue. The Company will record royalty revenues in the period certain cumulative sales targets are met by Grupo Ferrer."
http://bit.ly/14ESvjd
Also:
In March 2012, the Company entered into an amendment to the Ferrer Agreement. Ferrer and the Company agreed to eliminate a future potential milestone payment in exchange for Ferrer’s purchase of $3 million of the Company’s common stock. Ferrer purchased 241,936 shares of the Company’s common stock for $12.40 per share in March 2012, which reflected a premium on the fair value of the Company’s common stock of approximately $1,452,000.